Literature DB >> 9404057

Contents of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan.

M Sato1, Y Suzuki, T Okuda, K Yokotsuka.   

Abstract

The presence of resveratrol (3,5,4'-trihydroxystilbene) and its beta-glucoside, piceid (resveratrol-3-beta-D-glucopyranoside), together with their isomers in wine appears to be one of the beneficial factors conferring a protective effect against cardiovascular disease through red wine ingestion. A total of 42 red and white wines was collected in areas from Hokkaido to Kyushu in Japan. The wines were fractionated with a C18 Sep-pak cartridge, and the active principles were eluted with ethyl acetate. Crude trans- and cis-piceid were extracted from a Chinese medicine, 'Kojohkon' (Polygonum cuspidatum), and their retention times and UV absorption were confirmed by HPLC. trans- and cis-Resveratrol, and trans- and cis-piceid were analyzed in a short C18 HPLC column, and cis-resveratrol was quantified from the amount of cis-isomer converted from authentic trans-resveratrol that had been treated by UV irradiation. The content of piceid is shown as the resveratrol equivalent. The average content of total stilbene compounds was 4.37 mg/liter in red wines, while only 0.68 mg/liter in white wines. Red wines made from Pinot noir, Merlot, and Zweigeltrebe grapes all had a high resveratrol content.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404057     DOI: 10.1271/bbb.61.1800

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  14 in total

1.  The effect of salt stress on resveratrol and piceid accumulation in two Vitis vinifera L. cultivars.

Authors:  Imen Souid; Imene Toumi; Isidro Hermosín-Gutiérrez; Soumaia Nasri; Ahmed Mliki; Abdelwahed Ghorbel
Journal:  Physiol Mol Biol Plants       Date:  2019-04-06

2.  Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons.

Authors:  S Bastianetto; W H Zheng; R Quirion
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

3.  Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury.

Authors:  Tim West; Madeliene Atzeva; David M Holtzman
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

Review 4.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

5.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

6.  Resveratrol inhibits nicotinic stimulation-evoked catecholamine release from the adrenal medulla.

Authors:  Seong-Chang Woo; Gwang-Moon Na; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

Review 7.  The Potential of Resveratrol to Act as a Caloric Restriction Mimetic Appears to Be Limited: Insights from Studies in Mice.

Authors:  Kathrin Pallauf; Ilka Günther; Gianna Kühn; Dawn Chin; Sonia de Pascual-Teresa; Gerald Rimbach
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

8.  Resveratrol Derivative-Rich Melinjo Seed Extract Attenuates Skin Atrophy in Sod1-Deficient Mice.

Authors:  Kenji Watanabe; Shuichi Shibuya; Yusuke Ozawa; Naotaka Izuo; Takahiko Shimizu
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

Review 9.  Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies.

Authors:  Michael Yousef; Ioannis A Vlachogiannis; Evangelia Tsiani
Journal:  Nutrients       Date:  2017-11-10       Impact factor: 5.717

10.  Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma.

Authors:  Caroline Menard; Stéphane Bastianetto; Rémi Quirion
Journal:  Front Cell Neurosci       Date:  2013-12-26       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.